COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 175 filers reported holding COHERUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,508 | -9.2% | 24,200 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $99,649 | -19.2% | 23,337 | +29.4% | 0.00% | 0.0% |
| Q1 2023 | $123,318 | -11.3% | 18,029 | +2.8% | 0.00% | 0.0% |
| Q4 2022 | $138,956 | -14.2% | 17,545 | +4.2% | 0.00% | -50.0% |
| Q3 2022 | $162,000 | +33.9% | 16,832 | +0.5% | 0.00% | +100.0% |
| Q2 2022 | $121,000 | -43.5% | 16,753 | +0.9% | 0.00% | -50.0% |
| Q1 2022 | $214,000 | -18.6% | 16,605 | +0.8% | 0.00% | 0.0% |
| Q4 2021 | $263,000 | -0.8% | 16,467 | -0.2% | 0.00% | 0.0% |
| Q3 2021 | $265,000 | +21.0% | 16,507 | +4.3% | 0.00% | 0.0% |
| Q2 2021 | $219,000 | -10.6% | 15,830 | -5.7% | 0.00% | 0.0% |
| Q1 2021 | $245,000 | -14.9% | 16,779 | +1.2% | 0.00% | -33.3% |
| Q4 2020 | $288,000 | -8.3% | 16,582 | -3.1% | 0.00% | 0.0% |
| Q3 2020 | $314,000 | +38.9% | 17,118 | +35.2% | 0.00% | 0.0% |
| Q2 2020 | $226,000 | +13.0% | 12,663 | +2.6% | 0.00% | 0.0% |
| Q1 2020 | $200,000 | – | 12,348 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 200,000 | $1,448,000 | 1.54% |
| Tri Locum Partners LP | 376,486 | $2,726,000 | 1.12% |
| Perceptive Advisors | 3,645,471 | $26,393,000 | 0.83% |
| TANG CAPITAL MANAGEMENT LLC | 750,000 | $5,430,000 | 0.82% |
| Bridge City Capital, LLC | 162,146 | $1,174,000 | 0.62% |
| Knott David M Jr | 186,134 | $1,348,000 | 0.57% |
| Aristotle Capital Boston, LLC | 2,322,168 | $16,812,000 | 0.50% |
| Phocas Financial Corp. | 316,455 | $2,291,000 | 0.34% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $22,644,000 | 0.30% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $53,439,280 | 0.29% |